Why a baby’s gut matters: howearly bacteria may cause illness and how we can prevent it
Official title: The Role of Secreted Bacterial Effectors in Intestinal Dysbiosis and Systemic Spread
Funded at University of Virginia · NIH-11340404 · Data updated 2026-11-12
This grant looks at how early-life gut bacteria from group B strep can trigger infection and disease in newborns and what might stop it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | May 11, 2026 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $806,000 |
| NIH project number | 1R01AI199505-01 |
| Project ID | NIH-11340404 on NIH RePORTER |
Who could benefit from this research
✓Could help
Newborns and infants at risk of Group B Streptococcus-related illness, including those exposed to infected amniotic fluid or breast milk.
✕Less likely to help
Healthy newborns with no exposure to GBS infection may not benefit directly.
What this research studies
Researchers will study how a common newborn gut bacterium, Group B Streptococcus, interacts with the baby’s developing gut and immune barriers to potentially cause bloodstream infection. The project builds on animal and laboratory models to understand the role of specific bacterial secretion systems in virulence and immune evasion. With a focus on early life, the work aims to identify targets that could prevent late-onset infections in newborns. The findings could guide new therapies or preventive strategies for at-risk infants.
Why it matters
Potential benefit: If successful, the work could lead to new ways to prevent serious infections in newborns.
How similar studies have gone: Previous studies in animal models support the role of bacterial secretion systems in virulence, but human-specific mechanisms remain to be clarified.
Where this research is happening
-
University of Virginia
Charlottesville, United States Active
Researchers
- Principal investigator: Spencer, Brady L — University of Virginia
- Study coordinator: Spencer, Brady L
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance
This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.
-
Antibiotics, gut health, and skin reactions in kids
A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.
-
Novel therapeutic to protect the gut after radiation
A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.
-
A new GI-focused treatment to reduce radiation damage after exposure
A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.
-
How a mouth bacterium might fuel gum disease and heart risk
A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.